A new system enables the early detection of drug-induced liver toxicities in primary care
A study led by professionals from the Clínic-IDIBAPS and the Barcelona Esquerra Primary Healthcare Consortium (CAPSBE) has developed a system for t...
A study led by professionals from the Clínic-IDIBAPS and the Barcelona Esquerra Primary Healthcare Consortium (CAPSBE) has developed a system for t...
The group's research activity focuses on the study of viral hepatitis and genetic, autoimmune, and cholestatic liver diseases, with the aim of adva...
The IDIBAPS Management Committee has approved the leadership transition of the research group "Viral, genetic and immune-mediated liver diseases"....
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and cont...
The study shows how the average life of the virus is drastically reduced, in transplanted patients and cell cultures alike.
A study conducted by researchers from the Hospital Clínic-IDIBAPS and the CIBEREHD that has been published by the Journal of Hepatology shows that...
Researchers of the IDIBAPS-Hospital Clínic research group Viral, toxic and metabolic liver diseases and CIBEREHD have published a study in the Jour...